Steven Cohen Bristol Myers Squibb CO Transaction History

Point72 Asset Management, L.P.

$42.2 Billion
Q4 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,410,278 shares of BMY stock, worth $78.7 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

1,410,278

Previous 2,880,305 51.04%

Holding current value

$78.7 Million

Previous $149 Million 46.49%

% of portfolio

0.19%

Previous 0.41%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$51.92 - $59.94 $76.3 Million - $88.1 Million	-1,470,027 Reduced 51.04%	1,410,278 $79.8 Million
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $88.9 Million - $116 Million	2,242,312 Added 351.46%	2,880,305 $149 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $17.9 Million - $23.5 Million	444,106 Added 229.05%	637,993 $26.5 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $9.3 Million - $10.5 Million	193,887 New	193,887 $10.5 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $43.8 Million - $49 Million	756,964 Added 9051.35%	765,327 $44.4 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $532,806 - $591,598	8,363 New	8,363 $534,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $34,171 - $40,463	499 New	499 $35,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $35.7 Million - $41.6 Million	-665,200 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $39.4 Million - $46.1 Million	665,200 New	665,200 $39.4 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $16 Million - $17.5 Million	-259,100 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $72.5 Million - $81.5 Million	-1,221,576 Reduced 82.5%	259,100 $16.4 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $7.86 Million - $8.9 Million	136,087 Added 10.12%	1,480,676 $91.8 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $39.1 Million - $43.3 Million	680,135 Added 102.36%	1,344,589 $81.1 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $35.6 Million - $41.6 Million	649,521 Added 4349.57%	664,454 $39.1 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $692,891 - $1.01 Million	14,933 New	14,933 $832,000
Q3 2019 Nov 15, 2019	SELL	$42.77 - $50.71 $47.6 Million - $56.4 Million	-1,112,077 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $95.9 Million - $106 Million	-2,148,293 Reduced 65.89%	1,112,077 $50.4 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $42.8 Million - $51 Million	947,784 Added 40.98%	3,260,370 $156 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $6.17 Million - $8 Million	126,549 Added 5.79%	2,312,586 $120 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $67.9 Million - $76.6 Million	-1,230,861 Reduced 36.02%	2,186,037 $136 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $169 Million - $210 Million	3,341,898 Added 4455.86%	3,416,898 $189 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $2.4 Million - $2.76 Million	-40,000 Reduced 34.78%	75,000 $4.74 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $2.4 Million - $2.61 Million	40,000 Added 53.33%	115,000 $7.05 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $4.14 Million - $4.78 Million	75,000	75,000 $4.78 Million

Others Institutions Holding BMY

# of Institutions

2,751

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account